Mechanism of Action: Cytochrome P450 3A Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cytochrome P450 3A Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rubicon | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 078578-002 | Feb 26, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Dr Reddys Labs Sa | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 075389-003 | Dec 28, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Chartwell Rx | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 077069-003 | Oct 4, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |